X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1764) 1764
Publication (164) 164
Newsletter (81) 81
Book Review (30) 30
Newspaper Article (27) 27
Magazine Article (22) 22
Book Chapter (15) 15
Trade Publication Article (3) 3
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1421) 1421
female (1415) 1415
bacterial vaginosis (1010) 1010
vaginosis, bacterial - drug therapy (733) 733
index medicus (665) 665
adult (648) 648
vaginosis (595) 595
pregnancy (570) 570
women (430) 430
obstetrics & gynecology (376) 376
vaginosis, bacterial - microbiology (340) 340
infectious diseases (331) 331
metronidazole (312) 312
anti-bacterial agents - therapeutic use (309) 309
vagina - microbiology (306) 306
health aspects (297) 297
middle aged (278) 278
risk factors (267) 267
infections (256) 256
microbiology (253) 253
metronidazole - therapeutic use (244) 244
vaginosis, bacterial - diagnosis (242) 242
adolescent (241) 241
care and treatment (230) 230
treatment outcome (219) 219
pregnancy complications, infectious - drug therapy (215) 215
administration, intravaginal (202) 202
infection (196) 196
research (180) 180
immunology (179) 179
vaginitis (177) 177
bacteria (174) 174
prevalence (174) 174
young adult (173) 173
prevention (166) 166
vaginosis, bacterial - complications (162) 162
antibiotics (161) 161
anti-infective agents - therapeutic use (147) 147
metronidazole - administration & dosage (147) 147
drug therapy (146) 146
diagnosis (145) 145
medicine, general & internal (145) 145
sexually transmitted diseases (145) 145
microbiota (139) 139
probiotics (139) 139
vaginosis, bacterial - epidemiology (137) 137
vagina (136) 136
womens health (132) 132
recurrence (127) 127
pharmacology & pharmacy (126) 126
flora (122) 122
preterm birth (121) 121
hiv (119) 119
infant, newborn (119) 119
anti-bacterial agents - administration & dosage (118) 118
lactobacillus (117) 117
research article (117) 117
double-blind method (114) 114
male (113) 113
animals (111) 111
analysis (109) 109
clindamycin (109) 109
risk-factors (109) 109
prospective studies (106) 106
therapy (106) 106
candidiasis, vulvovaginal - drug therapy (105) 105
lactobacilli (101) 101
trichomonas vaginitis - drug therapy (101) 101
pregnant women (100) 100
risk (98) 98
medicine (97) 97
premature birth (97) 97
clindamycin - therapeutic use (96) 96
pregnant-women (96) 96
preterm delivery (95) 95
clinical trials (92) 92
medical research (92) 92
pregnancy outcome (90) 90
double-blind (89) 89
vaginosis, bacterial - prevention & control (89) 89
administration, oral (88) 88
obstetrics and gynecology (86) 86
pregnancy complications, infectious - diagnosis (86) 86
genital-tract (85) 85
gardnerella-vaginalis (82) 82
delivery (81) 81
gynecology (81) 81
obstetric labor, premature - prevention & control (80) 80
article (78) 78
chlamydia-trachomatis (78) 78
gardnerella vaginalis (77) 77
clindamycin - administration & dosage (76) 76
association (75) 75
probiotics - therapeutic use (75) 75
trichomoniasis (75) 75
anti-infective agents - administration & dosage (74) 74
disease transmission (74) 74
nonspecific vaginitis (73) 73
pregnancy complications, infectious - microbiology (73) 73
epidemiology (69) 69
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1761) 1761
Bulgarian (30) 30
French (21) 21
Spanish (20) 20
Russian (19) 19
German (14) 14
Polish (14) 14
Italian (12) 12
Chinese (11) 11
Hungarian (4) 4
Czech (3) 3
Danish (3) 3
Portuguese (2) 2
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 09/2009, Volume 116, Issue 10, pp. 1315 - 1324
Introduction  Abnormal vaginal flora (AVF) before 14 gestational weeks is a risk factor for preterm birth (PTB). The presence of aerobic microorganisms and an... 
wet mount microscopy | lactobacillary grades | prematurity | bacterial vaginosis | pregnancy outcome | Aerobic vaginitis | M. hominis | Bacterial vaginosis | Prematurity | Lactobacillary grades | Pregnancy outcome | Wet mount microscopy | LATE MISCARRIAGE | RISK | AMNIOTIC-FLUID | GENITAL-TRACT | DELIVERY | OBSTETRICS & GYNECOLOGY | WOMEN | TRICHOMONAS-VAGINALIS | UREAPLASMA-UREALYTICUM | hominis | ASSOCIATION | LABOR | Ureaplasma Infections - microbiology | Humans | Vaginitis - microbiology | Ureaplasma Infections - drug therapy | Premature Birth - diagnosis | Vaginitis - drug therapy | Mycoplasma hominis - isolation & purification | Pregnancy Trimester, First | Premature Birth - chemically induced | Metronidazole - adverse effects | Adult | Female | Pregnancy Complications, Infectious - microbiology | Parity | Anti-Infective Agents - adverse effects | Ureaplasma urealyticum - isolation & purification | Mycoplasma Infections - microbiology | Risk Factors | Mycoplasma Infections - drug therapy | Vaginosis, Bacterial - drug therapy | Pregnancy | Premature Birth - microbiology | Vaginosis, Bacterial - microbiology | Pregnancy Complications, Infectious - drug therapy | Pregnancy Outcome | Microorganisms | Reproductive system | Microbiology | Antibiotics | Premature birth | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 09/2015, Volume 92, pp. 105 - 122
Journal Article
Current Opinion in Infectious Diseases, ISSN 0951-7375, 02/2013, Volume 26, Issue 1, pp. 86 - 89
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 4/2013, Volume 56, Issue 8, pp. 1094 - 1100
Background. Mycoplasma genitalium (MG) is an emerging sexually transmitted infection (STI) that is potentially associated with reproductive tract sequelae in... 
Medical treatment failures | Chlamydia | Womens health | rRNA genes | General practice | Infections | Mycoplasma genitalium | ARTICLES AND COMMENTARIES | Reinfection | Epidemiology | Urethritis | young women | STI epidemiology | organism load | treatment failure | INFECTIOUS DISEASES | CHLAMYDIA-TRACHOMATIS | URETHRITIS | PERSISTENCE | MICROBIOLOGY | AZITHROMYCIN | PREVALENCE | IMMUNOLOGY | ASYMPTOMATIC MEN | PELVIC-INFLAMMATORY-DISEASE | REAL-TIME PCR | TRANSMISSION | INFECTION | Sexually Transmitted Diseases, Bacterial - microbiology | Humans | Drug Resistance, Bacterial | Sexually Transmitted Diseases, Bacterial - drug therapy | Incidence | Mycoplasma genitalium - genetics | Young Adult | Anti-Bacterial Agents - therapeutic use | RNA, Ribosomal, 23S - genetics | Treatment Failure | Communicable Diseases, Emerging - drug therapy | RNA, Bacterial - genetics | Adult | Female | Vaginosis, Bacterial - epidemiology | Communicable Diseases, Emerging - microbiology | Mycoplasma Infections - microbiology | Communicable Diseases, Emerging - epidemiology | Mycoplasma Infections - drug therapy | Bacterial Load | Australia - epidemiology | Vaginosis, Bacterial - drug therapy | Azithromycin - pharmacology | Point Mutation | Azithromycin - therapeutic use | Vaginosis, Bacterial - microbiology | Adolescent | Sexually Transmitted Diseases, Bacterial - epidemiology | Anti-Bacterial Agents - pharmacology | Mycoplasma Infections - epidemiology | Cohort Studies | Women | Treatment outcome | Care and treatment | Analysis | Health aspects | Risk factors
Journal Article
Journal Article